Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Benefits associated with IB-MECA in a model of experimental colitis

May 27, 2004

Vertex plans METRO study for merimepodib

May 27, 2004

Oral MNTX formulations complete phase I trials

May 27, 2004

OPC-6535 shows promise in the treatment of ulcerative colitis

May 27, 2004

Comparison of the efficacy of tenatoprazole and esomeprazole in inducing gastric acid suppression

May 27, 2004

Oral combination approaches with VX-950, VX-497 for HCV treatment; VX-950 comparable to BILN-2061

May 27, 2004

Rigel initiates phase I/II trial for R-803 in HCV

May 26, 2004

New European phase III trial for Zadaxin triple therapy in HCV

May 26, 2004

Efficacy and safety of tacrolimus in fistulizing Crohn's disease

May 26, 2004

Immunological changes induced by glatiramer acetate in an experimental colitis model

May 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...